Cargando…

Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics

The idiotype network is experimentally modified to provide protective immunity against various microbial pathogens. Both internal and non-internal image-idiotype antibodies can trigger specific immune responses to antigens. The current outbreak of Severe Acute Respiratory Syndrome 2 (SARS-2) has pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Naveed, Ahsan, Naz, Deeba, Rahman, Sajjad ur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380862/
https://www.ncbi.nlm.nih.gov/pubmed/34458584
http://dx.doi.org/10.1186/s41231-021-00097-y
_version_ 1783741257398353920
author Naveed, Ahsan
Naz, Deeba
Rahman, Sajjad ur
author_facet Naveed, Ahsan
Naz, Deeba
Rahman, Sajjad ur
author_sort Naveed, Ahsan
collection PubMed
description The idiotype network is experimentally modified to provide protective immunity against various microbial pathogens. Both internal and non-internal image-idiotype antibodies can trigger specific immune responses to antigens. The current outbreak of Severe Acute Respiratory Syndrome 2 (SARS-2) has provided a great opportunity to take advantage of idiotype / anti-idiotype antibodies as a protective regimen when no approved vaccine is available on earth. The current review identifies successful applications of idiotype/ anti-idiotype antibodies in various viral diseases and highlights their importance in COVID-19 pandemics. In the absence of vaccines and targeted therapies, polyclonal idiotype/ anti-idiotype antibodies against the viral structure may be a potential approach to the prevention and treatment of COVID-19 patients.
format Online
Article
Text
id pubmed-8380862
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83808622021-08-23 Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics Naveed, Ahsan Naz, Deeba Rahman, Sajjad ur Transl Med Commun Review The idiotype network is experimentally modified to provide protective immunity against various microbial pathogens. Both internal and non-internal image-idiotype antibodies can trigger specific immune responses to antigens. The current outbreak of Severe Acute Respiratory Syndrome 2 (SARS-2) has provided a great opportunity to take advantage of idiotype / anti-idiotype antibodies as a protective regimen when no approved vaccine is available on earth. The current review identifies successful applications of idiotype/ anti-idiotype antibodies in various viral diseases and highlights their importance in COVID-19 pandemics. In the absence of vaccines and targeted therapies, polyclonal idiotype/ anti-idiotype antibodies against the viral structure may be a potential approach to the prevention and treatment of COVID-19 patients. BioMed Central 2021-08-23 2021 /pmc/articles/PMC8380862/ /pubmed/34458584 http://dx.doi.org/10.1186/s41231-021-00097-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Naveed, Ahsan
Naz, Deeba
Rahman, Sajjad ur
Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
title Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
title_full Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
title_fullStr Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
title_full_unstemmed Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
title_short Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
title_sort idiotype/anti-idiotype antibodies: as a glorious savior in covid-19 pandemics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380862/
https://www.ncbi.nlm.nih.gov/pubmed/34458584
http://dx.doi.org/10.1186/s41231-021-00097-y
work_keys_str_mv AT naveedahsan idiotypeantiidiotypeantibodiesasaglorioussaviorincovid19pandemics
AT nazdeeba idiotypeantiidiotypeantibodiesasaglorioussaviorincovid19pandemics
AT rahmansajjadur idiotypeantiidiotypeantibodiesasaglorioussaviorincovid19pandemics